Ontology highlight
ABSTRACT:
SUBMITTER: Kagabu M
PROVIDER: S-EPMC7177858 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
Kagabu Masahiro M Nagasawa Takayuki T Sato Chie C Fukagawa Yasuko Y Kawamura Hanae H Tomabechi Hidetoshi H Takemoto Shuji S Shoji Tadahiro T Baba Tsukasa T
International journal of molecular sciences 20200327 7
Immune checkpoint inhibitors (ICIs) have demonstrated marked clinical effects worldwide, and "cancer immunotherapy" has been recognized as a feasible option for cancer treatment. Significant treatment responses have already been attained for malignant melanoma and lung cancer, ahead of gynecologic cancer. In cervical cancer, however, results are only available from phase II trials, not from phase III trials. Cervical cancer is a malignant tumor and is the fourth most common cancer among women wo ...[more]